FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969806830> ?p ?o ?g. }

• W2969806830 abstract "Extracorporeal carbon dioxide removal (ECCO2R) is a promising technique for the management of acute respiratory failure, but with a limited level of evidence to support its use outside clinical trials and/or data collection initiatives. We report a collaborative initiative in a large metropolis.To assess on a structural basis the rate of utilization as well as efficacy and safety parameters of 2 ECCO2R devices in 10 intensive care units (ICU) during a 2-year period.Seventy patients were recruited in 10 voluntary and specifically trained centers. The median utilization rate was 0.19 patient/month/center (min 0.04; max 1.20). ECCO2R was started under invasive mechanical ventilation (IMV) in 59 patients and non-invasive ventilation in 11 patients. The Hemolung Respiratory Assist System (Alung) was used in 53 patients and the iLA Activve iLA kit (Xenios Novalung) in 17 patients. Main indications were ultraprotective ventilation for ARDS patients (n = 24), shortening the duration of IMV in COPD patients (n = 21), preventing intubation in COPD patients (n = 9), and controlling hypercapnia and dynamic hyperinflation in mechanically ventilated patients with severe acute asthma (n = 6). A reduction in median VT was observed in ARDS patients from 5.9 to 4.1 ml/kg (p <0.001). A reduction in PaCO2 values was observed in AE-COPD patients from 67.5 to 51 mmHg (p< 0.001). Median duration of ECCO2R was 5 days (IQR 3-8). Reasons for ECCO2R discontinuation were improvement (n = 33), ECCO2R-related complications (n = 18), limitation of life-sustaining therapies or measures decision (n = 10), and death (n = 9). Main adverse events were hemolysis (n = 21), bleeding (n = 17), and lung membrane clotting (n = 11), with different profiles between the devices. Thirty-five deaths occurred during the ICU stay, 3 of which being ECCO2R-related.Based on a registry, we report a low rate of ECCO2R device utilization, mainly in severe COPD and ARDS patients. Physiological efficacy was confirmed in these two populations. We confirmed safety concerns such as hemolysis, bleeding, and thrombosis, with different profiles between the devices. Such results could help to design future studies aiming to enhance safety, to demonstrate a still-lacking strong clinical benefit of ECCO2R, and to guide the choice between different devices.ClinicalTrials.gov: Identifier: NCT02965079 retrospectively registered https://clinicaltrials.gov/ct2/show/NCT02965079." @default.
• W2969806830 created "2019-08-29" @default.
• W2969806830 creator A5003423056 @default.
• W2969806830 creator A5006012598 @default.
• W2969806830 creator A5018007709 @default.
• W2969806830 creator A5023138053 @default.
• W2969806830 creator A5033341176 @default.
• W2969806830 creator A5040027845 @default.
• W2969806830 creator A5044177639 @default.
• W2969806830 creator A5046135818 @default.
• W2969806830 creator A5046253650 @default.
• W2969806830 creator A5051484421 @default.
• W2969806830 creator A5053916099 @default.
• W2969806830 creator A5063195220 @default.
• W2969806830 creator A5068267365 @default.
• W2969806830 creator A5070071339 @default.
• W2969806830 creator A5072547311 @default.
• W2969806830 creator A5073851208 @default.
• W2969806830 creator A5073950436 @default.
• W2969806830 creator A5082787613 @default.
• W2969806830 creator A5087187401 @default.
• W2969806830 creator A5088668538 @default.
• W2969806830 date "2019-08-20" @default.
• W2969806830 modified "2023-10-15" @default.
• W2969806830 title "A 2-year multicenter, observational, prospective, cohort study on extracorporeal CO2 removal in a large metropolis area" @default.
• W2969806830 cites W1976284065 @default.
• W2969806830 cites W1979469936 @default.
• W2969806830 cites W2023871663 @default.
• W2969806830 cites W2040004550 @default.
• W2969806830 cites W2091813048 @default.
• W2969806830 cites W2091958988 @default.
• W2969806830 cites W2141800523 @default.
• W2969806830 cites W2145037555 @default.
• W2969806830 cites W2255272767 @default.
• W2969806830 cites W2256052213 @default.
• W2969806830 cites W2262320010 @default.
• W2969806830 cites W2413063916 @default.
• W2969806830 cites W2489891619 @default.
• W2969806830 cites W2536799499 @default.
• W2969806830 cites W2580954781 @default.
• W2969806830 cites W2587145778 @default.
• W2969806830 cites W2620208330 @default.
• W2969806830 cites W2687090754 @default.
• W2969806830 cites W2743447270 @default.
• W2969806830 cites W2763164264 @default.
• W2969806830 cites W2770192915 @default.
• W2969806830 cites W2801966455 @default.
• W2969806830 cites W2809748766 @default.
• W2969806830 cites W2898574258 @default.
• W2969806830 cites W2918002560 @default.
• W2969806830 cites W878407356 @default.
• W2969806830 doi "https://doi.org/10.1186/s40560-019-0399-8" @default.
• W2969806830 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6701003" @default.
• W2969806830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31452899" @default.
• W2969806830 hasPublicationYear "2019" @default.
• W2969806830 type Work @default.
• W2969806830 sameAs 2969806830 @default.
• W2969806830 citedByCount "16" @default.
• W2969806830 countsByYear W29698068302020 @default.
• W2969806830 countsByYear W29698068302021 @default.
• W2969806830 countsByYear W29698068302022 @default.
• W2969806830 countsByYear W29698068302023 @default.
• W2969806830 crossrefType "journal-article" @default.
• W2969806830 hasAuthorship W2969806830A5003423056 @default.
• W2969806830 hasAuthorship W2969806830A5006012598 @default.
• W2969806830 hasAuthorship W2969806830A5018007709 @default.
• W2969806830 hasAuthorship W2969806830A5023138053 @default.
• W2969806830 hasAuthorship W2969806830A5033341176 @default.
• W2969806830 hasAuthorship W2969806830A5040027845 @default.
• W2969806830 hasAuthorship W2969806830A5044177639 @default.
• W2969806830 hasAuthorship W2969806830A5046135818 @default.
• W2969806830 hasAuthorship W2969806830A5046253650 @default.
• W2969806830 hasAuthorship W2969806830A5051484421 @default.
• W2969806830 hasAuthorship W2969806830A5053916099 @default.
• W2969806830 hasAuthorship W2969806830A5063195220 @default.
• W2969806830 hasAuthorship W2969806830A5068267365 @default.
• W2969806830 hasAuthorship W2969806830A5070071339 @default.
• W2969806830 hasAuthorship W2969806830A5072547311 @default.
• W2969806830 hasAuthorship W2969806830A5073851208 @default.
• W2969806830 hasAuthorship W2969806830A5073950436 @default.
• W2969806830 hasAuthorship W2969806830A5082787613 @default.
• W2969806830 hasAuthorship W2969806830A5087187401 @default.
• W2969806830 hasAuthorship W2969806830A5088668538 @default.
• W2969806830 hasBestOaLocation W29698068301 @default.
• W2969806830 hasConcept C126322002 @default.
• W2969806830 hasConcept C141071460 @default.
• W2969806830 hasConcept C2776348555 @default.
• W2969806830 hasConcept C2776780178 @default.
• W2969806830 hasConcept C2777037550 @default.
• W2969806830 hasConcept C2777080012 @default.
• W2969806830 hasConcept C2777714996 @default.
• W2969806830 hasConcept C2778553927 @default.
• W2969806830 hasConcept C2779915274 @default.
• W2969806830 hasConcept C42219234 @default.
• W2969806830 hasConcept C71924100 @default.
• W2969806830 hasConceptScore W2969806830C126322002 @default.
• W2969806830 hasConceptScore W2969806830C141071460 @default.
• W2969806830 hasConceptScore W2969806830C2776348555 @default.
• W2969806830 hasConceptScore W2969806830C2776780178 @default.
• W2969806830 hasConceptScore W2969806830C2777037550 @default.

• next